What are the challenges of allogeneic stem cell transplant in myeloma?
Re-analysis of RESONATE-2 trial of ibrutinib vs chlorambucil in CLL
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL
Potential combination of ibrutinib with gamma delta T-cell therapy in CLL
Iris de Weerdt
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results